Amgen's Aranesp Increases Stroke Risk in Diabetic CKD Patients - Renal Business Today PDF Print
Renal Business Today"As the first, large-scale placebo-controlled study to examine the use of anemia therapy in diabetic CKD patients not on dialysis, the TREAT results

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.